Voloridge Investment Management’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
EC
TCM
AAA
S
WP
6CM
Voloridge Investment Management's ANAB Position: Q2 2026 in Review
Voloridge Investment Management reduced its AnaptysBio (ANAB) stake by 27% in Q2 2026, selling an estimated $1.3M and leaving 57,555 shares worth $3.88M. The position accounts for 0.02% of the portfolio, ranked #581.
Voloridge Investment Management first reported a position in ANAB in Q4 2017 and has held it in 16 quarters since. The position peaked at $11.1M in Q4 2025. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.
- Voloridge Investment Management held 57,555 shares of AnaptysBio worth $3.88M as of Q2 2026.
- Voloridge Investment Management sold 21,397 AnaptysBio shares in Q2 2026, an estimated $1.3M.
- AnaptysBio made up 0.02% of Voloridge Investment Management's portfolio in Q2 2026, its #581 holding.
- Voloridge Investment Management first reported a position in AnaptysBio in Q4 2017 and has held it in 16 quarters since.
- Voloridge Investment Management's AnaptysBio position peaked at $11.1M in Q4 2025.
- 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.
Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.